McKesson Canada is moving its Halifax distribution centre to Moncton next month, citing that city’s more centralized location as an advantage.The Montreal-based national pharmaceutical company now has three distribution centres in Atlantic Canada — St. John’s, N.L., Moncton and its facility in Lakeside Industrial Park, just west of downtown Halifax.However, the company will consolidate its Moncton and Halifax centres and move them into a new 167,000-square-feet facility in Moncton’s Caledonia Industrial Park on Jan. 29.The company’s Atlantic Canada regional office, also at the Lakeside location, will be moving to Moncton as well.The consolidation was a “business decision,” company spokesman David Bone said via an email from Montreal.“Our Moncton distribution centre was no longer able to meet our needs in terms of space.”The decision to consolidate was made “after a thorough review of all possibilities, including availability of suitable properties, and taking into account our operational needs,” he added.“This will enable us to service our customers in a more efficient manner while meeting evolving operating compliance measures. We believe it will be more efficient to serve our customers in the Maritimes from a single distribution centre, and based on our review of all possibilities, Moncton appeared to be a convenient central location in the context of our current and future business initiatives.”Bone said that activities at the Halifax distribution centre will be transferred in stages to “ensure a smooth transition.” Offices will be transferred at the end of January 2012; the warehouse will be transferred at end of February 2012.The move will affect about 50 people who work at the Halifax centre. Some positions will be transferred to Moncton, but Bone did not have an exact number of people.“We are committed to treating each impacted employee with great consideration, in accordance with our shared principles of respect and fairness, and we will work closely with them throughout this transition.”
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac...
-
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma...
-
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th...
-
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y...
-
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after...
-
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ...
-
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment